p300 catalytic inhibition selectively targets IRF4 oncogenic activity in multiple myeloma
Lenoir, F., McKeown, M., Giorgetti, G., Kobylarz, M., Hopkins, T., Glore, W., Shum, M., Calderon, Y., Carvajal, L., Mori, K., Gao, H., Zhou, M., Trotter, B., Dinsmore, C., Munshi, N., Lin, C., Fulciniti, M., Mariateresa, F., Rahl, P.To be published.